<DOC>
	<DOCNO>NCT00561444</DOCNO>
	<brief_summary>The goal behavioral research study look patient ' quality life treatment management prostate cancer .</brief_summary>
	<brief_title>Quality Life Study Prostate Cancer Patients</brief_title>
	<detailed_description>Questionnaires : You complete 2 questionnaire ask question quality life , urinary , bowel , sexual function , side effect may . You ask medication may take medical condition may . The questionnaire take 20 minute complete . You may complete questionnaire clinic , mail ( return postage include ) , ask question phone . If active surveillance ( check prostate cancer routine blood draw biopsy , without active treatment ) , fill questionnaire schedule receive treatment involve hormone . If receive therapy involve hormone , complete questionnaire receive treatment . If receive hormone therapy , complete questionnaire begin hormone therapy within 3 week start radiation . For participant , 3 6 month treatment complete , complete questionnaire . Starting 6 month finish treatment , complete questionnaire every 6 month 2 year . Starting 2 year treatment , complete questionnaire year 3 year . Length Study : All participant consider off-study complete last questionnaire . You take study early receive second treatment prostate cancer decide treatment active surveillance . This investigational study . Up 1448 patient enrol study . All enrol MD Anderson , MD Anderson Albuquerque , MD Anderson Cooper .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Primary treatment MD Anderson prostate cancer use : radical retropubic prostatectomy , robotic prostatectomy , photon external beam radiation , photon external beam radiation hormone therapy , proton radiation , radioisotopic implant , cryotherapy , active surveillance . 2 . Neoadjuvant , concurrent adjuvant androgen ablation conjunction photon external beam radiation allow great 6 month total duration . Hormone therapy give LHRH agonist without antiandrogen . 3 . Pathologic diagnosis prostate adenocarcinoma 4 . AJCC ( VI ) stage T1T3b N0M0 5 . Ability read , write , fill selfsurvey questionnaire 6 . Patients may simultaneously enrol MD Anderson treatment laboratory protocol . The EPIC Survey use protocol protocol 20070209 patient enrolled protocol complete one document survey point . Simultaneous enrollment survey protocols handle similar manner . 1 . Histology adenocarcinoma 2 . Stage T4 , nodal distant metastasis 3 . Prior treatment prostate cancer except neoadjuvant , concurrent adjuvant androgen deprivation 6 month less duration patient treat photon radiation . Hormone therapy modality allow . 4 . Chemotherapy molecular target therapy primary , neoadjuvant adjuvant treatment 5 . Treatment another pelvic malignancy , include surgery radiation 6 . Treatment another malignancy chemotherapy complete within one year less treatment prostate cancer . 7 . Inflammatory bowel disease ( eg . Crohn 's Ulcerative Colitis ) 8 . Patients 18 year young .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Radical retropubic prostatectomy</keyword>
	<keyword>Robotic prostatectomy</keyword>
	<keyword>Photon external beam radiation</keyword>
	<keyword>Photon external beam radiation hormone therapy</keyword>
	<keyword>Proton radiation</keyword>
	<keyword>Radioisotopic implant</keyword>
	<keyword>Cryotherapy</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Survey</keyword>
	<keyword>QOL</keyword>
</DOC>